Welcome to our dedicated page for AMETEK INC/ SEC filings (Ticker: AME), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMETEK INC/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMETEK INC/'s regulatory disclosures and financial reporting.
AMETEK, Inc. has filed a notice for the planned sale of 6,388 shares of its common stock through broker Charles Schwab & Co., Inc. on the NYSE. The shares to be sold have an stated aggregate market value of $1,309,890.00. They were acquired on 12/22/2025 via an employee stock option exercise using a broker payment for a cashless exercise on the same date. Shares of AMETEK common stock outstanding were 230,203,873 as of the figures provided; this is a baseline figure, not the amount being sold.
AMETEK, Inc. reported an insider transaction by its Electronic Instruments president involving company common stock on 12/15/2025. The officer exercised stock options for 14,310 shares of common stock at an exercise price of $63.37 per share; these options became exercisable in three equal annual installments beginning on March 20, 2021.
On the same date, the officer sold 14,310 shares of AMETEK common stock at a price of $202.1131 per share, with sale prices ranging from $202.00 to $202.44. After these transactions, the officer directly owned 42,589 shares, held 3,029 shares through a 401k plan, 348 shares held by a spouse, and 13,553 shares of Common Stock/SERP, with no stock options remaining.
AMETEK, Inc. has filed a notice that an employee plans to sell 14,310 shares of its common stock on or about 12/15/2025 on the NYSE through Charles Schwab. The filing reports an aggregate market value for the planned sale of $2,892,238 based on the market data used in the form.
The shares were acquired the same day through an employee stock option exercise structured as a broker-facilitated cashless exercise. The form indicates that 230,203,873 shares of AMETEK common stock are outstanding, so the planned sale represents a small portion of the company’s equity base. The seller also represents that they are not aware of any material adverse information about AMETEK’s current or prospective operations that has not been publicly disclosed.
AMETEK Inc. chief executive officer and director David A. Zapico reported gifts and a trust sale of company stock. On 12/12/2025, he made a gift of 3,514 shares of AMETEK common stock and a separate gift of 28,390 shares to a family trust. Following these gifts, he directly held 317,051 shares of AMETEK stock.
The family trust, for which Zapico disclaims beneficial ownership, then sold 28,390 shares of AMETEK common stock on the same date at an average price of $201.76 per share, with individual trades ranging from $201.12 to $202.00. After this transaction, the trust held no AMETEK shares, while Zapico continued to report substantial direct ownership.
AMETEK insider plans to sell 28,390 common shares under Rule 144. The shares are to be sold on the NYSE through Morgan Stanley Smith Barney LLC, with an aggregate market value of $5,727,682.51. AMETEK had 230,203,873 common shares outstanding, and the planned sale date is listed as 12/12/2025.
The securities to be sold were acquired on 06/04/2001 through the exercise of stock options under a registered plan, in two blocks of 16,219 and 12,171 shares paid in cash. Over the past three months, Dave Zapico reported selling 88,000 AMETEK shares on 11/26/2025 for gross proceeds of $17,300,000.00. The signer represents that they are not aware of undisclosed material adverse information about AMETEK’s current or prospective operations.
AMETEK, Inc. (AME) reported an insider transaction by its Chief Executive Officer and director. On 11/25/2025, the reporting person exercised 88,000 stock options at an exercise price of $63.37 per share, acquiring the same number of AMETEK common shares.
On the same date, the insider sold an aggregate of 88,000 common shares in three transactions: 7,432 shares at a weighted average price of $194.89, 25,815 shares at $195.82, and 54,753 shares at $196.86, with detailed price ranges provided in the notes. After these transactions, the insider directly owned 348,955 shares of common stock, plus 23,982 common stock/ SERP units and 11,080 stock options.
AMETEK, Inc. (AME) received a Form 144 notice covering a planned sale of 88,000 shares of its common stock. The shares are to be sold through Charles Schwab & Co., Inc. on the NYSE, with an approximate sale date of 11/25/2025 and an indicated aggregate market value of $17,282,126.00.
The securities were acquired on 11/25/2025 via an employee stock option exercise using a broker payment for a cashless exercise. As context, the table lists 230,203,873 shares of AMETEK common stock outstanding. This filing is a notice of a proposed sale under Rule 144 rather than an issuer offering.
AMETEK, Inc. (AME) disclosed an insider transaction by its Chief Commercial Officer. On 11/12/2025, the officer sold 2,700 shares of common stock at a price of $200 per share, coded “S” for sale.
Following the transaction, the officer beneficially owned 28,293 shares, reported as direct ownership. No derivative securities were listed in the filing.
AMETEK, Inc. (AME) received a Form 144 notice for a proposed sale of 2,700 common shares. The filing lists an aggregate market value of 540000.00 and names Charles Schwab & Co., Inc. as broker. The shares are slated for sale on or about 11/12/2025 on the NYSE.
The securities were acquired on 02/15/2024 through PSU/RSU equity compensation from AMETEK, Inc., in the same amount of 2,700 shares. As context, AMETEK reported 230203873 shares outstanding in the notice.
AMETEK, Inc. (AME) announced leadership changes in its finance organization. Thomas M. Montgomery, Senior Vice President, Comptroller and Principal Accounting Officer, intends to retire effective January 1, 2026, and will remain a Senior Advisor through 2026. The company elected Robert J. Amodei as Senior Vice President, Controller and Principal Accounting Officer effective January 1, 2026. Amodei, 58, has served as Vice President, Assistant Controller since April 2025 and previously held roles including Vice President, Group Controller for the Electromechanical Group. The company stated there are no arrangements or family relationships related to his selection, and Amodei will be an executive officer. A related press release was furnished as Exhibit 99.1.